The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
The Keap1-Nrf2 system and diabetes mellitus
Open accessAbstract
Nrf2 (NF-E2-related factor 2) plays a key role in the protection of vertebrates against environmental stress by contributing to the inducible expression of detoxification and antioxidant enzymes. Keap1 (Kelch-like ECH-associated protein 1) is a sensor for oxidative and electrophilic stresses. Keap1 also acts as an E3 ubiquitin ligase substrate-recognition subunit that specifically targets Nrf2. Keap1 causes Nrf2 to be degraded through the ubiquitin-proteasome pathway and thus ensures that Nrf2 is constitutively suppressed under unstressed conditions. Upon exposure to oxidative or electrophilic stress, Keap1 loses its ability to ubiquitinate Nrf2. Many lines of evidence have recently clarified that the Keap1-Nrf2 system also plays critical roles in the maintenance of cellular homeostasis. One of the most salient examples is the contribution of Keap1-Nrf2 to metabolic and energy-balance regulation. In particular, how the Keap1-Nrf2 system protects the body against diabetes mellitus and how perturbations in this system provoke the disease condition are now under intense investigation. This review will summarize the recent progress made in this area.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“despite its beneficial role in cellular protection and cancer prevention, Nrf2 also has a harmful “dark side” in cancer [156].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [156]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova‐Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,210
H 2 O 2 , a Necessary Evil for Cell Signaling
Rhee, S. G. (2006) · Science · doi:10.1126/science.1130481 · Cited by 2,160
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,473
Research works printed but not linked: 2
- Thimmulappa, 2002, Cancer Res., 62, 5196
- Chartoumpekis, 2013, Curr. Diabetes Rev., 9, 137
Cited by
Sorted by citations
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,510
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995
Self-citationTu, W., Wang, H., Li, S., Liu, Q., & Sha, H. (2018) · Aging and Disease · doi:10.14336/ad.2018.0513 · Cited by 727
“Numerous evidences have recently elucidated the role of Keap1–Nrf2 system in metabolic and energy-balance regulation [103].”
BackgroundInfluentialSKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans
Blackwell, T. K., Steinbaugh, M. J., Hourihan, J. M., Ewald, C. Y., & Isik, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.008 · Cited by 622
“various aspects of metabolism and other functions [1,3–5].”
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
“Pathologic ROS formation in insulin-sensitive tissues, as well as in pancreas, has been found in T2DM patients, resulting in severe impairment of both insulin secretion by pancreatic b cells and insulin action in peripheral tissues (Uruno et al., 2015) (Fig.”
BackgroundAbed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.008 · Cited by 336
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4826724 · Cited by 311
Yamada, T., Murata, D., Adachi, Y., Itoh, K., Kameoka, S., Igarashi, A., Kato, T., Araki, Y., Huganir, R. L., Dawson, T. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.014 · Cited by 292
Ding, X., Jian, T., Wu, Y., Zuo, Y., Li, J., Lv, H., Ma, L., Ren, B., Zhao, L., Li, W., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.018 · Cited by 258
Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
Hasnain, S. Z., Prins, J. B., & McGuckin, M. A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0232 · Cited by 254
“IL22 alters these genes independently of oxidative stress and can therefore protect cells from subsequent stressors, distinguishing IL22 from the Nrf2 transcription factor that is induced by oxidative stress (Uruno et al. 2015).”
BackgroundActivation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiß, E. H. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 208
Mikhed, Y., Görlach, A., Knaus, U. G., & Daiber, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.05.008 · Cited by 189
“The nuclear factor erythroid related factor 2 (Nrf2), is a member of the cap ‘n’ collar family of transcription factors [48].”
BackgroundNrf2 Suppresses Oxidative Stress and Inflammation in App Knock-In Alzheimer’s Disease Model Mice
Uruno, A., Matsumaru, D., Ryoke, R., Saito, R., Kadoguchi, S., Saigusa, D., Saito, T., Saido, T. C., Kawashima, R., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00467-19 · Cited by 168
“Soluble A (1-40) (F) and A (1-42) (G) in the cerebral cortex and the hippocampus (Hippo) of four AppNLGF and six AppNLGF::Keap1FA/FA 11-month-old mouse brains are shown.”
BackgroundMethodInfluentialEmerging ROS-Modulating Technologies for Augmentation of the Wound Healing Process
Polaka, S., Katare, P., Pawar, B., Vasdev, N., Gupta, T., Rajpoot, K., Sengupta, P., & Tekade, R. K. (2022) · ACS Omega · doi:10.1021/acsomega.2c02675 · Cited by 169
Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases
da Costa, R. M., Rodrigues, D., Pereira, C. A., da Silva, J. F., Alves, J. V., Lobato, N. S., & Tostes, R. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00382 · Cited by 168
Hosseini, H., Teimouri, M., Shabani, M., Koushki, M., Khorzoughi, R. B., Namvarjah, F., Izadi, P., & Meshkani, R. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105667 · Cited by 160
Pharmacotherapy of type 2 diabetes: An update and future directions
DeMarsilis, A. J., Reddy, N., Boutari, C., Filippaios, A., Sternthal, E., Katsiki, N., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155332 · Cited by 173
Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
Hung, P., Hsu, Y., Chen, T., & Lin, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111857 · Cited by 154
“An antioxidative transcription factor, NF-E2-related factor 2 (NRF2), is known to activate the transcription of glutathione peroxidase 2 (GPX2) to increase oxidative stress, inflammation, and apoptosis, leading to permanent injury with renal fibrosis and DKD [100].”
BackgroundNrf2 Improves Leptin and Insulin Resistance Provoked by Hypothalamic Oxidative Stress
Yagishita, Y., Uruno, A., Fukutomi, T., Saito, R., Saigusa, D., Pi, J., Fukamizu, A., Sugiyama, F., Takahashi, S., & Yamamoto, M. P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.064 · Cited by 129
Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism
Uruno, A., Yagishita, Y., Katsuoka, F., Kitajima, Y., Nunomiya, A., Nagatomi, R., Pi, J., Biswal, S. S., & Yamamoto, M. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.01095-15 · Cited by 126
“Nrf2 contributes to the maintenance of metabolic homeostasis (5); for example, Nrf2 induction in pancreatic cells markedly suppresses oxidative-stress-mediated dysfunction (18, 19).”
BackgroundInfluentialBousquet, J. J., Antó, J. M., Czarlewski, W., Haahtela, T., Fonseca, S. C., Iaccarino, G., Blain, H., Vidal, A., Sheikh, A., Akdiş, C. A., et al. (2020) · Allergy · doi:10.1111/all.14549 · Cited by 123
“Nrf2 may be involved in diseases associated with insulin resistance 70-72 .”
BackgroundMendonca, P., & Soliman, K. F. A. (2020) · Antioxidants · doi:10.3390/antiox9080659 · Cited by 126
Redox regulation of proteasome function
Lefaki, M., Papaevgeniou, N., & Chondrogianni, N. (2017) · Redox Biology · doi:10.1016/j.redox.2017.07.005 · Cited by 117
“Nrf2 upregulation restores the proteasome activities and mediates adaptation to oxidative stress [77], in contrast to bortezomib-”
ResultKeap1‐Nrf2 signaling pathway in angiogenesis and vascular diseases
Guo, Z., & Mo, Z. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3053 · Cited by 114
“Nrf2 has emerged as an important target in diabetes and related vascular complications (Uruno et al., 2015).”
BackgroundThe KEAP1-NRF2 System and Neurodegenerative Diseases
Uruno, A., & Yamamoto, M. P. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0234 · Cited by 113
“Accumulating lines of evidence clearly support the notion that the activation of NRF2 signaling suppresses oxidative stress and inflammation or protects metabolic tissues from oxidative stresses (Liu et al., 2022; Uruno et al., 2015; Ya-gishita et al., 2014).”
Erkens, R., Kramer, C. M., Lückstädt, W., Panknin, C., Krause, L., Weidenbach, M., Dirzka, J., Krenz, T., Mergia, E., Suvorava, T., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.10.409 · Cited by 108
“diabetes) [10] and vascular aging [11].”
The Coming Age of Flavonoids in the Treatment of Diabetic Complications
Caro-Ordieres, T., Marín‐Royo, G., Opazo-Ríos, L., Jiménez-Castilla, L., Moreno, J. A., Gómez‐Guerrero, C., & Egido, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020346 · Cited by 113
Nrf2 as a Key Player of Redox Regulation in Cardiovascular Diseases
Barančı́k, M., Gresová, L., Barteková, M., & Dovinová, I. (2016) · Physiological Research · doi:10.33549/physiolres.933403 · Cited by 106
Slocum, S. L., Skoko, J., Wakabayashi, N., Aja, S. M., Yamamoto, M. P., Kensler, T. W., & Chartoumpekis, D. V. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.040 · Cited by 108
Lu, M., Wang, P., Qiao, Y., Jiang, C., Ge, Y., Flickinger, B., Malhotra, D. K., Dworkin, L. D., Liu, Z., & Gong, R. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101275 · Cited by 104
“In a state of low oxidative stress, Nrf2 is sequestered in the cytoplasm and associated with an inhibitor protein called Kelch-like enoyl-CoA hydratase-associated protein 1 (Keap1) [22,27].”
BackgroundRegulatory Role of Nrf2 Signaling Pathway in Wound Healing Process
Süntar, I. P., Çetinkaya, S., Panieri, E., Saha, S., Buttari, B., Profumo, E., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26092424 · Cited by 103
“Nrf2/Kelch-like ECH-associated protein 1 (Nrf2/Keap1) is a crucial signaling pathway that protects against environmental stressors such as ROS, electrophilic and proteotoxic stress [15].”
BackgroundNrf2 deficiency deteriorates diabetic kidney disease in Akita model mice
Liu, Y., Uruno, A., Saito, R., Matsukawa, N., Hishinuma, E., Saigusa, D., Liu, H., & Yamamoto, M. P. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102525 · Cited by 97
“Nrf2 is known to regulate the expression of metabolic genes and antioxidant genes [66].”
BackgroundA Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds
Paunkov, A., Chartoumpekis, D. V., Ziros, P. G., & Sykiotis, G. P. (2019) · Antioxidants · doi:10.3390/antiox8090353 · Cited by 94
Zhang, Y., Zuo, J., Yan, L., Yang, C., Li, Q., Wu, S., Chen, L., Thring, R. W., Yang, Y., Gao, Y., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c02555 · Cited by 95
Zhou, Z.-Y., Ren, L.-W., Zhan, P., Yang, H.-Y., Chai, D.-D., & Yu, Z.-W. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.21 · Cited by 92
NRF2 and Diabetes: The Good, the Bad, and the Complex
Dodson, M. B., Shakya, A., Anandhan, A., Chen, J., Garcia, J. G. N., & Zhang, D. D. (2022) · Diabetes · doi:10.2337/db22-0623 · Cited by 100
Zhou, L., Xu, D., Sha, W., Shen, L., Lu, G., Yin, X., & Wang, M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0710-y · Cited by 90
“The controller of Nrf2 activity is Keap1 (Kelch-like ECH– associated protein), an adaptor protein for Cullin3-based ubiquitin E3 ligase by ubiquitination and subsequent degradation of Nrf2 [15].”
BackgroundContribution of Oxidative Stress and Impaired Biogenesis of Pancreatic β-Cells to Type 2 Diabetes
Ježek, P., Jabůrek, M., & Plecitá‐Hlavatá, L. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7656 · Cited by 89
Dou, Y., Huang, R., Li, Q., Liu, Y., Li, Y., Chen, H., Ai, G., Xie, J., Zeng, H., Chen, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111312 · Cited by 88
Wu, J., Jiang, Z., Zhang, H., Liang, W., Huang, W., Zhang, H., Li, Y., Wang, Z., Wang, J., Jia, Y., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.034 · Cited by 88
Type I interferons and endoplasmic reticulum stress in health and disease
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.10.004 · Cited by 83
“Similarly, PERK also phosphorylates NRF2 which encourages NRF2's detachment from its cytosolic repressor protein, Kelch-like Ech associated protein 1 (KEAP1) (Chien et al., 2015; Cullinan et al., 2003; Del Vecchio et al., 2014; Holland and Fishbein, 2010; Uruno et al., 2015) .”
Silva‐Palacios, A., Königsberg, M., & Zazueta, C. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.005 · Cited by 84
“Recently, the Keap1-Nrf2 system was proposed to play an important role in maintaining glucose metabolism through insulin secretion and glucose utilization, as well as by regulating lipid metabolism (Uruno et al., 2015).”
BackgroundZhou, S., Wang, P., Qiao, Y., Ge, Y., Wang, Y., Quan, S., Yao, R., Zhuang, S., Wang, L. J., Du, Y., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050565 · Cited by 82
Kim, M., & Jeon, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052846 · Cited by 81
“Nrf2 is a master regulator of AREdriven genes in pancreatic β-cells [196,197].”
BackgroundJubaidi, F. F., Zainalabidin, S., Mariappan, V., & Budin, S. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176043 · Cited by 81
Lee, H., & Lim, Y. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.016 · Cited by 80
Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention
Bugno, M., Daniel, M., Chepelev, N. L., & Willmore, W. G. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.08.001 · Cited by 78
Zhang, Y., Wang, H., Zhang, L., Yuan, Y., & Yu, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.185 · Cited by 75
Role and Regulation of Glutathione Metabolism in Plasmodium falciparum
Müller, S. (2015) · Molecules · doi:10.3390/molecules200610511 · Cited by 73
“Nrf2 in other organisms [142].”
Tiberi, J., Cesarini, V., Stefanelli, R., Canterini, S., Fiorenza, M. T., & Rosa, P. L. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111802 · Cited by 75
“, 2008), metabolic (Uruno et al., 2015), cardiovascular”
Pu, D., Zhao, Y., Chen, J., Sun, Y., Lv, A., Zhu, S., Luo, C., Zhao, K., & Xiao, Q. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.017 · Cited by 71
Robson, R., Kundur, A., & Singh, I. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.029 · Cited by 70
“OONO and the resulting O2 in T2DM) is present, Keap1 loses its ability to ubiquitinate the nuclear factor, leading to its activation [47].”
BackgroundNRF2 signalling pathway: New insights and progress in the field of wound healing
Liu, Y., Yang, X., Liu, Y., Jiang, T., Ren, S., Chen, J., Xiong, H., Yuan, M., Li, W., Machens, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16597 · Cited by 71
Zhang, J., Wang, S., Zeng, Z., Qin, Y., Shen, Q., & Li, P. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103843 · Cited by 70
Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment
Shen, S., Zhong, H., Zhou, X., Li, G., Zhang, C., Zhu, Y., & Yang, Y. M. (2024) · Pharmaceutical Biology · doi:10.1080/13880209.2024.2314705 · Cited by 74
“Nrf2 is a transcription factor that plays a role in countering oxidative stress by inducing gene expression associated with anti-oxidant processes (Zheng et al. 2011; Uruno et al. 2015; Cheng et al. 2019).”
BackgroundSong, Y., Wen, L., Sun, J., Bai, W., Jiao, R., Hu, Y., Peng, X., He, Y., & Ou, S. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.30323 · Cited by 66
“Under unstressed conditions, Nrf2 exists as an inactive complex with its repressor Keap1, which negatively regulates Nrf2 by ubiquitination and proteasomal degradation (32, 33).”
BackgroundZhao, Y., Jayachandran, M., & Xu, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.105 · Cited by 66
Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK–NRF2 pathway
Cunha, D. A., Cito, M., Carlsson, P., Vanderwinden, J., Molkentin, J. D., Bugliani, M., Marchetti, P., Eizirik, D. L., & Cnop, M. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.89 · Cited by 66
“ARE-containing genes, including enzymes involved in glutathione biosynthesis, H2O2 scavengers and chemical detoxification.(45) At variance with the antioxidant response”
BackgroundTherapeutic potential of ginsenosides on diabetes: From hypoglycemic mechanism to clinical trials
Shao, J., Jiang, J., Zou, J., Yang, M., Chen, F., Zhang, Y.-J., & Jia, L. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103630 · Cited by 65
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
Vargas-Mendoza, N., Morales‐González, Á., Morales-Martínez, M., Soriano-Ursua, M. A., Delgado‐Olivares, L., Sandoval-Gallegos, E. M., Madrigal‐Bujaidar, E., Álvarez‐González, I., Madrigal‐Santillán, E., & Morales‐González, J. A. (2020) · Biomedicines · doi:10.3390/biomedicines8050122 · Cited by 66
“Previous studies indicated that Nrf2 regulates the antioxidant enzyme system in pancreatic β-cells [96], contributes to protection against inflammation, and regulates autophagy and the expression of proteosome catalytic subunits in β-cells [97,98].”
BackgroundMechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach
Potilinski, M. C., Lorenc, V. E., Perisset, S., & Gallo, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072351 · Cited by 62
“Perturbations on the Keap1/Nrf2 system, like in diabetes mellitus, promote the disease condition [74].”
BackgroundFan, H., Ma, X., Lin, P., Kang, Q., Zhao, Z., Wang, L., Sun, D., Cheng, J., & Li, Y. (2017) · Medical Science Monitor · doi:10.12659/msm.907530 · Cited by 61
“Nrf2 arises as a critical regulator of liver metabolic homeostasis, regulating fatty acid synthesis and the progression from steatosis to more-severe liver pathologies [22,23].”
BackgroundMathur, A., Pandey, V. K., & Kakkar, P. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.550 · Cited by 60
Stasi, L. C. D. (2023) · Pharmaceuticals · doi:10.3390/ph16040511 · Cited by 60
Wang, X., Chen, H., Liu, J., Ouyang, Y., Wang, D., Bao, W., & Liu, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160716483 · Cited by 58
“NRF2 plays a key role in the protection of vertebrates against environmental stress by contributing to the inducible expression of detoxification and antioxidant enzymes [35].”
Dong, Y., Wang, Z., Chen, C., Wang, P., & Fu, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127267 · Cited by 57
Wang, R., Liu, L., Liu, H., Wu, K., An, J., Wang, Q., Liu, Y., Bai, L., Qi, B., Qi, B., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3727 · Cited by 56
“5c), while ROS production was increased (Fig.”
InfluentialCr (VI) induces abnormalities in glucose and lipid metabolism through ROS/Nrf2 signaling
Li, X., He, S., Zhou, J., Yu, X., Li, L., Liu, Y., & Li, W. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112320 · Cited by 55
Zhao, Y., Dong, D., Reece, E. A., Wang, A. R., & Yang, P. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.10.040 · Cited by 50
Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice
Yagishita, Y., Uruno, A., Chartoumpekis, D. V., Kensler, T. W., & Yamamoto, M. P. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0355 · Cited by 49
Zuo, Y., Chen, L., He, X., Ye, Z., Li, L., Liu, Z., & Zhou, S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s298950 · Cited by 50
“expression is downregulated under high glucose (HG) condition.(12) Hu et al(13) found that the mice knocked out NRF2 are more sensitive to oxidative damage and respond”
BackgroundmiRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy
Ji, C., Li, C., Liu, W., Yan, B., Hu, X., & Yang, F. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0067 · Cited by 48
“Nrf2 inducers have been shown to prevent the development of DPN (Uruno et al. 2015).”
BackgroundJiménez‐Osorio, A. S., González-Reyes, S., García‐Niño, W. R., Moreno-Macías, H., Rodríguez-Arellano, M. E., Vargas‐Alarcón, G., Zúñiga, J., Barquera, R., & Pedraza‐Chaverrí, J. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7367641 · Cited by 47
“On the other hand, Kim [36] reported that there were no associations between the rs1800566 polymorphism and BMI, blood pressure, lipid profile, HbA1c, postprandial glucose, and homeostasis model assessment-insulin resistance (HOMA-IR).”
BackgroundLiu, W., Zhang, Y., Zheng, M., Ye, Y., Shi, M., Wang, X., Cao, L., & Wang, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156027 · Cited by 52
The Keap1–Nrf2 protein–protein interaction: A suitable target for small molecules
Schmoll, D., Engel, C. K., & Glombik, H. (2017) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2017.10.001 · Cited by 43
Li, G.-H., Li, Y., Jiao, P., Zhao, Y., Hu, H., Lou, H., & Shen, T. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7309073 · Cited by 42
“The activation of Nrf2-regulated antioxidant response relieved the pathogenesis and progression of diabetes [79, 80].”
Carnosol as a Nrf2 Activator Improves Endothelial Barrier Function Through Antioxidative Mechanisms
Li, X., Zhang, Q., Hou, N., Li, J., Liu, M., Peng, S., Zhang, Y., Luo, Y., Zhao, B., Wang, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040880 · Cited by 42
“As a key pathway for oxidative stress, the Keap1/Nrf2/ARE system plays an important role in the study of diabetes [12].”
BackgroundHussain, Y., Khan, H. Z., Alsharif, K. F., Khan, A. H., Aschner, M., & Saso, L. (2022) · Molecules · doi:10.3390/molecules27134145 · Cited by 41
“In diabetes mellitus, Nrf2, in addition to its protective response, exerts other significant functions that contribute to the management of diabetes mellitus [37].”
BackgroundThe novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice
Higashi, C., Kawaji, A., Tsuda, N., Hayashi, M., Saito, R., Yagishita, Y., Suzuki, T., Uruno, A., Nakamura, M., Nakao, K., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.044 · Cited by 44
“, 2014) and that Nrf2 contributes to the pathogenesis of metabolic disorders associated with oxidative stress (Suzuki and Yamamoto, 2015; Uruno and Motohashi, 2011; Uruno et al., 2015).”
BackgroundCai, J., Zhu, Y., Zuo, Y., Tong, Q., Zhang, Z., Yang, L., Li, X., & Yi, G.-Q. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10626 · Cited by 41
Katsu-Jiménez, Y., Vazquez‐Calvo, C., Maffezzini, C., Halldin, M., Peng, X., Freyer, C., Wredenberg, A., Giménez-Cassina, A., Wedell, A., & Arnér, E. S. J. (2019) · Diabetes · doi:10.2337/db18-0557 · Cited by 37
“Indeed, both TXNIP and Nrf2 are known to display tissue-specific effects in their strong influences on metabolic pathways and tissue integrity (3,15,25,30).”
BackgroundPopineau, L., Morzyglod, L., Carré, N., Caüzac, M., Bossard, P., Prip‐Buus, C., Lenoir, V., Ragazzon, B., Fauveau, V., Robert, L., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00170-16 · Cited by 37
Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
Carpi-Santos, R., & Calaza, K. D. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0961-8 · Cited by 38
Kumar, A. T., Katz, L. S., Schulz, A. M., Kim, M.-S., Honig, L. B., Li, L. Q., Davenport, B., Homann, D., Garcı́a-Ocaña, A., Herman, M. A., et al. (2018) · Diabetes · doi:10.2337/db17-0943 · Cited by 37
Zhang, X., Zhang, Y., Zhou, M., Xie, Y., Dong, X., Bai, F., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.792977 · Cited by 37
Xu, X., Sun, J., Chang, X., Wang, J., Luo, M., Wintergerst, K. A., Miao, L., & Cai, L. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12900 · Cited by 36
“in the patients with T2DM may play a crucial role in the development of diabetic complications [23, 31].”
BackgroundSuccinylation of a KEAP1 sensor lysine promotes NRF2 activation
Ibrahim, L. H., Stanton, C. R., Nutsch, K., Nguyen, T. T. A., Li-Ma, C., Ko, Y., Lander, G. C., Wiseman, R. L., & Bollong, M. J. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.014 · Cited by 36
Zhang, X., Zhang, B., Li, L., Li, X., Zhang, J., & Chen, G. (2022) · Food & Function · doi:10.1039/d2fo00595f · Cited by 36
Fonseca, S. C., Rivas, I., Romaguera, D., Quijal-Zamorano, M., Czarlewski, W., Vidal, A., Fonseca, J., Ballester, J., Antó, J. M., Basagaña, X., et al. (2020) · medRxiv · doi:10.1101/2020.07.06.20147025 · Cited by 35
“The Nrf2 (nuclear factor erythroid 2 p45-related factor 2), a transcription factor that protects against oxidative stress, may be involved in diseases associated with insulin-resistance (22-24).”
BackgroundGuan, Y., Zhou, L., Zhang, Y., Tian, H., Li, A., & Han, X. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.06.004 · Cited by 34
Mann, G. E., & Forman, H. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.002 · Cited by 34
New insights into anti-diabetes effects and molecular mechanisms of dietary saponins
Zhou, Y., & Xu, B. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2101425 · Cited by 37
“…is a vital signaling pathway to protect against oxidative and electrophilic stresses by promoting the expressions of phase II enzymes and antioxidant genes, such as heme oxygenase 1(HO-1), GSH, and NAD(P) H quinone dehydrogenase 1 (NQO1) (David et al. 2017; Uruno, Yagishita, and Yamamoto 2015).”
BackgroundZhu, Y., Ren, C., Zhang, M., & Zhong, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00166 · Cited by 33
“As we know, Nrf2 which is activated by oxidative stress acts as a critically important regulator of antioxidant response by modulating expression of ARE-containing genes, including enzymes involved in hydrogen peroxide scavengers, GSH biosynthesis and chemical detoxification (39).”
BackgroundInfluentialChlordane exposure causes developmental delay and metabolic disorders in Drosophila melanogaster
Wu, Q., Du, X., Feng, X., Cheng, H., Chen, Y., Lu, C., Wu, M., & Tong, H. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112739 · Cited by 33
Khalili, F., Vaisi‐Raygani, A., Shakiba, E., Kohsari, M., Dehbani, M., Naseri, R., Asadi, S., Rahimi, Z., Rahimi, Z., & Rahimi, Z. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24163 · Cited by 33
Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus
Liu, Y., Wang, D., & Yang, L. (2022) · Current Drug Targets · doi:10.2174/1389450123666220429082702 · Cited by 35
McDonnell, C., Leánez, S., & Pol, O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180998 · Cited by 32
Jiang, M.-H., Li, D.-C., Piao, J.-M., Li, J.-Y., Sun, H., Chen, L.-P., Chen, S., Pi, J., Zhang, R., Chen, R., et al. (2020) · Science of the Total Environment · doi:10.1016/j.scitotenv.2020.138652 · Cited by 30
Wang, K., Liang, Y., Su, Y., & Wang, L. (2020) · Biochemical Journal · doi:10.1042/bcj20200402 · Cited by 31
Metadata
- Authors
- Uruno, A., Yagishita, Y., & Yamamoto, M.
- Affiliations
- Tohoku University (JP)
- Corresponding author
- Uruno, Akira
- Yamamoto, Masayuki
- Venue
- Archives of Biochemistry and Biophysics
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 566
- Pages
- 76-84
- ISSN
- 0003-9861 (ISSN-L)
- OpenAlex
- W2091259533
- Cited by
- 231
- References
- 109
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 19 · 2023: 20 · 2022: 26 · 2021: 23 · 2020: 28 · 2019: 24 · 2018: 20 · 2017: 13 · 2016: 16 · 2015: 20
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Archives of Biochemistry and Biophysics (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Science, Sports and Culture
- Create Revolutionary Technological Seeds for Science and Technology Innovation program (CREST) of the Japanese Technology Agency
- Japan Society for the Promotion of Science (24249015, 90396474, 26893008)
- Takeda Foundation
- Naito Foundation
- Japanese Foundation for Applied Enzymology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Keap1, Nrf2, diabetes mellitus, oxidative stress, electrophilic stress, ubiquitin-proteasome system, E3 ubiquitin ligase, antioxidant defense, metabolic homeostasis, energy balance
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Diabetes Mellitus, Type 2, Gene Expression Regulation, Humans, Signal Transduction, Oxidative Stress, Ubiquitin-Protein Ligases, Proteasome Endopeptidase Complex, Intracellular Signaling Peptides and Proteins, Insulin-Secreting Cells, NF-E2-Related Factor 2, Ubiquitination, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review